← FDA Drug Approvals (Drugs@FDA)

PEMETREXED

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-05-20

Drug application

FDA Application #

ANDA090352

Application type

Abbreviated New Drug Application (Generic)

Brand name

PEMETREXED

Generic name

Pemetrexed Sodium

Active ingredients

PEMETREXED SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

None (Tentative Approval)

Sponsor

TEVA PHARMS USA

First approval

2019-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown